Sumbare Wellness review

Very few sellers treat a low dose as its own program, and this one does. A named GLP-1 microdose treatment sits in the menu next to semaglutide and tirzepatide, with its own page, described as a gentler protocol aimed at metabolic health, body composition and appetite balance rather than maximum weight loss — which is close to the case this site spends its time making. The pricing structure sounds right alongside it: flat rate, no consultation charge, and explicitly no surcharge when the dose changes. Then the page ends without a number. The microdose program begins with a conversation, neither full-dose page carries a figure either, and the single public price is a banner marked as confirmed only after a provider has reviewed you — which makes it an opening quote rather than a rate anyone can plan around. Nothing is charged if you are not approved, which is a genuine protection and worth having. One more thing belongs in a reader's assessment: the outcome chart on the front page is footnoted to placebo-controlled trials of compounded semaglutide and tirzepatide. Compounded preparations are not what those trials tested, and lending a compounded program that authority is a claim the evidence behind it does not support.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1,300/mo is the full published spread on this site

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Sumbare Wellness does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Sumbare Wellness is one of the few providers here that treats a low dose as its own program rather than the first rung of a ladder. "GLP-1 Microdose" sits in the menu beside semaglutide and tirzepatide, with its own page, and it is described in almost exactly the terms this site uses: a lower therapeutic dose aimed at metabolic health, body composition and appetite balance rather than maximum weight loss. The pricing structure sounds right too — flat rate, no consultation charge, and explicitly no surcharge when the dose changes. Then the page ends without a number. The microdose program "begins with a conversation", the full-dose pages carry no figure either, and the single public price is a homepage banner marked as confirmed only after a provider has reviewed the patient. So the one question a microdoser arrives with cannot be answered before signing up. One further thing a reader should weigh: the outcome chart on the homepage is sourced to placebo-controlled trials of compounded semaglutide and tirzepatide. Compounded preparations are not what those trials tested — the 24-week evidence comes from the branded products — and borrowing it for a compounded program lends the number an authority it has not earned.

No price is published for the microdose program, or for either full-dose program — it "begins with a conversation".

• The one public figure is annotated "confirmed after provider review", so it is a quote rather than a rate.
• Its homepage outcome chart is footnoted to placebo-controlled trials of compounded formulations; those trials tested the branded products.

Sumbare Wellness is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• What a flat price costs at a low dose
• Titration planner